Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients

BACKGROUND: Bezlotoxumab significantly reduces the incidence of recurrent Clostridioides difficile infection (CDI); however, limited data are available in solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. METHODS: We conducted a single-center retrospective analysis com...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Johnson, Tanner M, Howard, Amanda H, Miller, Matthew A, Allen, Lorna L, Huang, Misha, Molina, Kyle C, Bajrovic, Valida
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Major Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274359/
https://ncbi.nlm.nih.gov/pubmed/34262988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab294
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky